These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10832919)

  • 21. Estimating false positives and negatives in brain networks.
    de Reus MA; van den Heuvel MP
    Neuroimage; 2013 Apr; 70():402-9. PubMed ID: 23296185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of causality in judgment under uncertainty.
    Krynski TR; Tenenbaum JB
    J Exp Psychol Gen; 2007 Aug; 136(3):430-50. PubMed ID: 17696692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rating exposure control using Bayesian decision analysis.
    Hewett P; Logan P; Mulhausen J; Ramachandran G; Banerjee S
    J Occup Environ Hyg; 2006 Oct; 3(10):568-81. PubMed ID: 16998991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cluster-level statistical inference in fMRI datasets: The unexpected behavior of random fields in high dimensions.
    Bansal R; Peterson BS
    Magn Reson Imaging; 2018 Jun; 49():101-115. PubMed ID: 29408478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [False positive results or what's the probability that a significant P-value indicates a true effect?].
    Cucherat M; Laporte S
    Therapie; 2017 Sep; 72(4):421-426. PubMed ID: 28577824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic association study in psychiatry: analytical evaluation and a recommendation.
    Carey G
    Am J Med Genet; 1994 Dec; 54(4):311-7. PubMed ID: 7726202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal type I and type II error pairs when the available sample size is fixed.
    Ioannidis JP; Hozo I; Djulbegovic B
    J Clin Epidemiol; 2013 Aug; 66(8):903-910.e2. PubMed ID: 23664493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: a hierarchical model using multi-center data.
    Stock EM; Stamey JD; Sankaranarayanan R; Young DM; Muwonge R; Arbyn M
    Cancer Epidemiol; 2012 Apr; 36(2):153-60. PubMed ID: 21856264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple testing in large-scale genetic studies.
    Bouaziz M; Jeanmougin M; Guedj M
    Methods Mol Biol; 2012; 888():213-33. PubMed ID: 22665284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory false positives: true, false, or uncertain?
    Cox LA
    Risk Anal; 2007 Oct; 27(5):1083-6; author reply 1087-9. PubMed ID: 18076480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance not statistical significance: a simple Bayesian alternative to p values.
    Burton PR; Gurrin LC; Campbell MJ
    J Epidemiol Community Health; 1998 May; 52(5):318-23. PubMed ID: 9764283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roaming through methodology. XXXII. False test results].
    van der Weijden T; van den Akker M
    Ned Tijdschr Geneeskd; 2001 May; 145(19):906-8. PubMed ID: 11387865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Information derived from sensitization test methods: test sensitivity, false positives and false negatives.
    Basketter DA; Kimber I
    Contact Dermatitis; 2007 Jan; 56(1):1-4. PubMed ID: 17177701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistics provide guidance for indigenous organic carbon detection on Mars missions.
    Sephton MA; Carter JN
    Astrobiology; 2014 Aug; 14(8):706-13. PubMed ID: 25061905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays.
    Zhang XD
    J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All tests are imperfect: Accounting for false positives and false negatives using Bayesian statistics.
    Qian SS; Refsnider JM; Moore JA; Kramer GR; Streby HM
    Heliyon; 2020 Mar; 6(3):e03571. PubMed ID: 32211545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Over- and Underestimation of Success Rates].
    Höder J; Eisemann N; Hüppe A
    Gesundheitswesen; 2015 Jun; 77(6):426-31. PubMed ID: 25001904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Bayesian decision procedure for testing multiple hypotheses in DNA microarray experiments.
    Gómez-Villegas MA; Salazar I; Sanz L
    Stat Appl Genet Mol Biol; 2014 Feb; 13(1):49-65. PubMed ID: 24317791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Strategy to Replace the Mouse Bioassay for Detecting and Identifying Lipophilic Marine Biotoxins by Combining the Neuro-2a Bioassay and LC-MS/MS Analysis.
    Bodero M; Gerssen A; Portier L; Klijnstra MD; Hoogenboom RLAP; Guzmán L; Hendriksen PJM; Bovee TFH
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30545061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.